Literature DB >> 14159267

CORTICOTROPIN IN TREATMENT OF OCULAR MYASTHENIA; A CONTROLLED CLINICAL TRIAL.

F W MOUNT.   

Abstract

Keywords:  ANXIETY; BLOOD SUGAR; CLINICAL RESEARCH; CORTICOTROPIN; DRUG THERAPY; EDEMA; EUPHORIA; EYE MANIFESTATIONS; EYE MOVEMENTS; GERIATRICS; GLYCOSURIA; MYASTHENIA GRAVIS; PLACEBOS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14159267     DOI： 10.1001/archneur.1964.00460200010002

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  6 in total

1.  Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.

Authors:  Michael Benatar; Michael P Mcdermott; Donald B Sanders; Gil I Wolfe; Richard J Barohn; Richard J Nowak; Michael Hehir; Vern Juel; Hans Katzberg; Rabi Tawil
Journal:  Muscle Nerve       Date:  2016-01-27       Impact factor: 3.217

Review 2.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

3.  [Symptomatic myasthenia in ocular myopathy].

Authors:  A Prill; H J Meyer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1969

4.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 5.  Medical and surgical treatment for ocular myasthenia.

Authors:  Michael Benatar; Henry Kaminski
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

6.  Treatment of ocular myasthenia with corticotrophin.

Authors:  F B Gibberd; F Navab; C L Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.